Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

Healixia events

  1. classroom_web.jpg
    11 May '20

    Introduction to Regulatory Affairs 2020 - POSTPONED


    The course is addressed to people new to regulatory affairs who want to acquire a comprehensive foundation; to regulatory professionals wishing to update their knowledge, and to all collaborators working in close relationship with regulatory affairs and wishing to understand the role of the department.

    The program proposes an introduction to the legal, scientific, organisational and administrative aspects of medical products given by experienced tutors from university, FAMHP and industry.

  2. Conference_web.jpg
    12 May '20

    Workshop: Pioneering malaria challenge trials in Belgium: from theory to practice in a Phase I unit - POSTPONED


    This workshop offers unique insights about Belgium’s pioneer malaria-VIS trials from the scientific community, the sponsor’s and the investigator’s perspective.

  3. Annual conference.jpg
    26 May '20

    Healixia annual conference - POSTPONED


    More information soon

    Save the date!

Show all meetings


  1. March 26, 2020

    Coronavirus: FAMHP seizes postal parcels containing counterfeit and other illegal medicines against COVID-19

    Heard from FAMHP

    Coronavirus: FAGG neemt postpakketten met namaak en andere illegale geneesmiddelen tegen COVID-19 in beslag

    Coronavirus : l'AFMPS saisit des colis postaux contenant des médicaments contrefaits et d’autres médicaments illégaux contre le COVID-19

    Read more

  2. March 26, 2020

    Coronavirus: Belgian guideline for the management of clinical trials during the coronavirus pandemic

    Heard from FAMHP

    A national guideline is available to complement European guidelines for the management of clinical trials during the coronavirus pandemic.

    Read more

  3. March 25, 2020

    Urgent mesures from the Luxembourg Authorities

    Here you will find an order which regulates the supply of medicines in Luxembourg and a general ban on the export of medicines.

    Read more

We thank our partners for their support. Click on the logos for more information: